287 related articles for article (PubMed ID: 8096069)
41. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
Savige JA; Gallicchio M; Georgiou T; Davies DJ
Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
[TBL] [Abstract][Full Text] [Related]
42. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
[TBL] [Abstract][Full Text] [Related]
43. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease.
Romas E; Paspaliaris B; d'Apice AJ; Elliott PR
Aust N Z J Med; 1992 Dec; 22(6):652-9. PubMed ID: 1489288
[TBL] [Abstract][Full Text] [Related]
46. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
47. [Prevalence of antiepithelial cell antibody in systemic vasculitis and identification of the target antigen thereof].
Zheng WJ; Tang FL; Zhao Y; Chen H; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3272-6. PubMed ID: 16409818
[TBL] [Abstract][Full Text] [Related]
48. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
49. Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.
Chanseaud Y; Tamby MC; Guilpain P; Reinbolt J; Kambouchner M; Boyer N; Noël LH; Guillevin L; Boissier MC; Mouthon L
J Autoimmun; 2005 Mar; 24(2):169-79. PubMed ID: 15829409
[TBL] [Abstract][Full Text] [Related]
50. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
Gross WL; Reinhold-Keller E
Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
[TBL] [Abstract][Full Text] [Related]
51. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
52. Microscopic polyangiitis (microscopic polyarteritis).
Jennette JC; Thomas DB; Falk RJ
Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
[TBL] [Abstract][Full Text] [Related]
53. [Microscopic polyarteritis].
Lauque D; Estivals M; Tubery M; Pourrat J; Carles P
Rev Pneumol Clin; 1993; 49(6):277-82. PubMed ID: 7915043
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies in primary systemic vasculitis.
Savage CO; Lockwood CM
Adv Intern Med; 1990; 35():73-92. PubMed ID: 1967893
[TBL] [Abstract][Full Text] [Related]
55. [Anti-cytoplasm antibodies of neutrophil polynuclear antibodies and associated diseases].
Chevailler A; Renier G; Subra JF
Ann Med Interne (Paris); 1991; 142(7):530-42. PubMed ID: 1686380
[No Abstract] [Full Text] [Related]
56. Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies.
Ronco P; Verroust P; Mignon F; Kourilsky O; Vanhille P; Meyrier A; Mery JP; Morel-Maroger L
Q J Med; 1983; 52(206):212-23. PubMed ID: 6193553
[TBL] [Abstract][Full Text] [Related]
57. [Diagnosis and therapy in systemic vasculitis with renal involvement].
Andrassy K; Ritz E
Ther Umsch; 1994 Dec; 51(12):813-8. PubMed ID: 7784994
[TBL] [Abstract][Full Text] [Related]
58. Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis.
Holmén C; Elsheikh E; Christensson M; Liu J; Johansson AS; Qureshi AR; Jalkanen S; Sumitran-Holgersson S
J Am Soc Nephrol; 2007 Sep; 18(9):2497-508. PubMed ID: 17699811
[TBL] [Abstract][Full Text] [Related]
59. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study.
Pettersson E; Heigl Z
Clin Nephrol; 1992 May; 37(5):219-28. PubMed ID: 1351434
[TBL] [Abstract][Full Text] [Related]
60. [A study of antiendothelial cell antibodies in Behcet's disease].
Zheng WJ; Zhao Y; Tang FL; Dong Y
Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):910-3. PubMed ID: 16409728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
